Myomo, Inc. (MYO) Research

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

Market snapshot

Symbol
MYO
Price
$1.28
Day change
-9.86%
Market cap
$49.5M
P/E ratio
-3.58x
52-week range
0.605-2.68
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$1.10

Peer companies

  • electroCore, Inc. (ECOR)
  • Hyperion DeFi, Inc. (HYPD)
  • IGC Pharma, Inc. (IGC)
  • MIRA Pharmaceuticals, Inc. (MIRA)
  • Milestone Scientific Inc. (MLSS)
  • Modular Medical, Inc. (MODD)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • Nexalin Technology, Inc. (NXL)

Recent insider activity

  • Kovelman Harry — F-InKind (10442 shares) on 2026-06-12
  • Mitchell Micah — F-InKind (9061 shares) on 2026-06-12
  • HENRY DAVID A — F-InKind (10969 shares) on 2026-06-12
  • Mitchell Micah — F-InKind (6529 shares) on 2026-06-08
  • Kovelman Harry — F-InKind (7635 shares) on 2026-06-08

Open Myomo, Inc. (MYO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.